Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:HEXO

HEXO (HEXO) Stock Price, News & Analysis

HEXO logo

About HEXO Stock (NYSE:HEXO)

Advanced Chart

Key Stats

Today's Range
$0.66
$0.71
50-Day Range
$0.69
$1.44
52-Week Range
$0.66
$3.84
Volume
305,500 shs
Average Volume
880,508 shs
Market Capitalization
$31.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

Receive HEXO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter.

HEXO Stock News Headlines

Kamala’s final humiliation
Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behind closed doors with some of America’s savviest investors. The obscure, little-known companies we believe could 5x, even 10x, under Trump’s second term…
Hexagon Composites ASA (HEXO.XD)
See More Headlines

HEXO Stock Analysis - Frequently Asked Questions

HEXO Corp. (NYSE:HEXO) announced its quarterly earnings results on Tuesday, December, 14th. The company reported ($5.04) earnings per share for the quarter, missing analysts' consensus estimates of ($1.12) by $3.92. The firm earned $39.75 million during the quarter, compared to analysts' expectations of $45.36 million. HEXO had a negative net margin of 235.33% and a negative trailing twelve-month return on equity of 74.04%.

Shares of HEXO reverse split on Monday, December 19th 2022. The 1-14 reverse split was announced on Monday, December 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that HEXO investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Tilray (TLRY), Organigram (OGI), Cronos Group (CRON), NVIDIA (NVDA) and Meta Platforms (META).

Company Calendar

Last Earnings
12/14/2021
Today
1/22/2025
Fiscal Year End
7/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Fax
N/A
Employees
1,277
Year Founded
N/A

Profitability

Net Income
$-845,900,000.00
Net Margins
-235.33%
Pretax Margin
-239.21%

Debt

Sales & Book Value

Annual Sales
$146.20 million
Book Value
$2.44 per share

Miscellaneous

Free Float
41,933,000
Market Cap
$31.24 million
Optionable
Optionable
Beta
1.35
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSE:HEXO) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners